ENDRA Life Sciences (NDRA) Inventory (2016 - 2024)

ENDRA Life Sciences has disclosed Inventory across 9 years of filings, most recently posting $2.7 million for Q3 2024.

• In Q3 2024, Inventory fell 1.66% year-over-year to $2.7 million; the TTM figure through Sep 2024 stood at $2.7 million (down 1.66% YoY), while the FY2023 annual figure was $2.6 million, down 0.83% from the prior year.
• Inventory held at $2.7 million in Q3 2024, from $2.7 million in the prior quarter.
• Over the last five years, Inventory for NDRA reached as high as $2.8 million in Q2 2023 and fell as low as $174935.0 in Q1 2020.
• The 5-year median for Inventory is $2.4 million (2022), against an average of $1.8 million.
• Annual changes were most pronounced in 2020 — Inventory jumped 419.75% — and 2024, when it dropped 1.66%.
• A 5-year view of Inventory shows it stood at $589620.0 in 2020, then soared by 117.87% to $1.3 million in 2021, then surged by 105.88% to $2.6 million in 2022, then fell by 0.83% to $2.6 million in 2023, then rose by 3.4% to $2.7 million in 2024.
• According to Business Quant data, Inventory over the past three periods registered $2.7 million, $2.7 million, and $2.7 million for Q3 2024, Q2 2024, and Q1 2024 respectively.